Drug Safety

, Volume 29, Issue 10, pp 1008–1008 | Cite as

ABSTRACTS: ISoP Annual Conference ‘Joining Forces for Managing Risks’ Liège, Belgium 11–13 October, 2006

  • G. Trifirò
  • V. Arcoraci
  • S. Moretti
  • D. U. Tari
  • M. Alacqua
  • A. P. Caputi
Abstracts
  • 12 Downloads

Keywords

Marketing Statin Primary Prevention Secondary Prevention Scientific Evidence 

References

  1. 1.
    Agenzia Italiana del farmaco (AIFA), 2003. L’uso dei farmaci in Italia. Rapporto OsMed 2003. Available at website: http://www.agenziafarmaco.it/edi_osmed_2003.html Accessed on March 12, 2006Google Scholar
  2. 2.
    Agenzia Italiana del farmaco (AIFA), 2004. L’uso dei farmaci in Italia. Rapporto OsMed 2004. Available at website: http://www.agenziafarmaco.it/edi_osmed_2004.html Accessed on March 12, 2006Google Scholar

Copyright information

© Adis Data Information BV 2006

Authors and Affiliations

  • G. Trifirò
    • 1
  • V. Arcoraci
    • 1
  • S. Moretti
    • 2
  • D. U. Tari
    • 2
  • M. Alacqua
    • 1
  • A. P. Caputi
    • 1
    • 3
  1. 1.Department of Clinical and Experimental Medicine and PharmacologyUniversity of MessinaItaly
  2. 2.Caserta 1 Local Health ServiceCasertaItaly
  3. 3.IRCCS Centro Neurolesi “Bonino-Pulejo”MessinaItaly

Personalised recommendations